X-Linked Severe Combined Immunodeficiency clinical trials at UCLA
2 in progress, 1 open to eligible people
Lentiviral Gene Transfer for SCID-X1 with Low Dose Targeted Busulfan Conditioning
open to eligible males ages 0-5
This is a phase I/II open label multi-center study in which patients will receive low dose targeted busulfan followed by infusion of autologous CD34+ selected bone marrow or mobilized peripheral blood cells transduced with the G2SCID vector.…
Los Angeles, California and other locations
Natural History Study of SCID Disorders
Sorry, accepting new patients by invitation only
This study is a prospective evaluation of children with Severe Combined Immune Deficiency (SCID) who are treated under a variety of protocols used by participating institutions. In order to determine the patient, recipient and transplant-related…
Los Angeles, California and other locations
Our lead scientists for X-Linked Severe Combined Immunodeficiency research studies include Satiro De Oliveira, MD.
Last updated: